Neurocrine Biosciences (NBIX) Fails to deliver data

Key failure to deliver metrics for Neurocrine Biosciences :

• Last SEC data release: 2026-01-14
• Last 15 days FTD volume: NZ$0.87 M
• Last 3 months FTD volume: NZ$5.02 M
• Last 12 months FTD volume: NZ$30.19 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Neurocrine Biosciences (NBIX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Neurocrine Biosciences (NBIX) - since 2013

Neurocrine Biosciences (NBIX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	NZ$56.21 M	NZ$0.12 B	🇺🇸 USA
AbbVie ABBV	NZ$49.63 M	NZ$98.25 M	🇺🇸 USA
Eli Lilly LLY	NZ$0.20 B	NZ$0.41 B	🇺🇸 USA
Repligen RGEN	NZ$6.47 M	NZ$21.79 M	🇺🇸 USA
Athersys ATHX	NZ$0.09 M	NZ$0.71 M	🇺🇸 USA
ANI Pharmaceuticals ANIP	NZ$2.61 M	NZ$5.4 M	🇺🇸 USA
Palatin Technologies PTN	NZ$0.78 M	NZ$0.84 M	🇺🇸 USA
Royalty Pharma RPRX	NZ$24.13 M	NZ$0.20 B	🇬🇧 UK